Amarin | AMRN - Trade Creditors


Amarin reported $40.43M in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
AbbVie USD 33.3B 29.71B Jun/2026
Alnylam Pharmaceuticals USD 135.4M 27.38M Sep/2026
Amarin USD 40.43M 21.63M Sep/2026
AstraZeneca USD 23.57B 679M Sep/2026
BioCryst Pharmaceuticals USD 14.58M 3.12M Sep/2026
DBV Technologies USD 13.8M 25.7M Sep/2026
GlaxoSmithKline GBP 15.63B 1.29B Sep/2026
Halozyme Therapeutics USD 33.55M 9.94M Sep/2026
Heron Therapeutics USD 8.38M 3.27M Sep/2026
Ionis Pharmaceuticals USD 27.11M 20.59M Sep/2026
Nektar Therapeutics USD 10.03M 744K Mar/2026
Neurocrine Biosciences USD 754.1M 612.1M Sep/2026
Novartis USD 4.24B 15M Sep/2026